← Leaderboards
Liva Harinantenaina Rakotondraibe
Ohio State University
$586,807
Attributed
$1,232,233
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $727.1K · FY2017–23$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,232,233 · 3
By mechanism
R56$648,358 · 1
R21$426,375 · 1
R03$157,500 · 1
Top collaborators
- Peter M Piermarini3 shared
- Xiaolin Cheng1 shared
Most similar at Ohio State University
Same institution · by research overlap
- Donald H Dean$2,788,164
- Michael K Chan$2,906,549
- Xiaolin Cheng$1,415,585
Others in their field
Other Emerging Leaders on “Family”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$49,374,001
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,270,371
- Lynn Briscoe · Leidos Biomedical Research, Inc.$23,229,499
- Badri N Vardarajan · University Of Miami School Of Medicine$20,570,414
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,109,927
Research focus
FamilyNatural ProductsStructurePlantsAdultUnited States National Institutes Of HealthResponseMachine LearningSafetyBotanicalsCognitive BenefitsAgingAcidsAntioxidantsChikungunyaCognition DisordersCommunitiesAedesAmino AcidsCarbonBiologicalBiological MarkersAnalytical MethodCell Nucleus
Grant awards (5)
DEVELOPMENT OF AN IN-HOUSE PROTON SPIN NETWORK DATABASE TO CHARACTERIZE THE PHARMACOPHORES OF CENTELLA ASIATICA FOR STANDARDIZATION AND QUALITY CONTROL$78,750
R03 · FY2023 · AT · contact PI
Developing botanical-derived chemical tools for controlling mosquito vectors$648,358
R56 · FY2022 · AI
DEVELOPMENT OF AN IN-HOUSE PROTON SPIN NETWORK DATABASE TO CHARACTERIZE THE PHARMACOPHORES OF CENTELLA ASIATICA FOR STANDARDIZATION AND QUALITY CONTROL$78,750
R03 · FY2022 · AT · contact PI
Development of plant-derived, resistance-breaking mosquitocides for controlling vectors of Zika virus$233,250
R21 · FY2018 · AI
Development of plant-derived, resistance-breaking mosquitocides for controlling vectors of Zika virus$193,125
R21 · FY2017 · AI